Lactic-acid bacteria supplement fermented dairy products with human behavior-modifying neuroactive compounds

Journal of Pharmacy and Nutrition Sciences

Volumn 4, Issue 3, 2014, Pages 199-206

  Oleskin, Alexander V ^a   Zhilenkova, Olga G ^b   Shenderov, Boris A ^b   Amerhanova, Adelaide M ^b   Kudrin, Vladimir S ^c   Klodt, Peter M ^c  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^c INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

Aggressiveness; Behavior modification; Biopolitics; Bulgaricus; Catecholamines; Dominance; Fermented dairy products; Lactobacillus casei; Lactobacillus delbrueckii subsp; Lactobacillus helveticus; Microbial endocrinology; Neuroactive amino acids; Neuromediators; Probiotic lactobacilli

Indexed keywords

EID: 84940243844     PISSN: 22233806     EISSN: 19275951     Source Type: Journal    
DOI: 10.6000/1927-5951.2014.04.03.5     Document Type: Article

References (37)

1. Lyte M. The role of microbial endocrinology in infectious disease. J Endocrinol 1993; 137: 343-5. http://dx.doi.org/10.1677/joe.0.1370343
2. Lyte M. The microbial organ in the gut as a driver of homeostasis and disease. Med Hypotheses 2010; 74: 634-8. http://dx.doi.org/10.1016/j.mehy.2009.10.025
3. Lyte M. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays 2011; 33: 574-81. http://dx.doi.org/10.1002/bies.201100024
4. Lyte M. Microbial endocrinology in the microbe-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog 2013; 9(11): e1003726. http://dx.doi.org/10.1371/journal.ppat.1003726
5. Shenderov BA. Impact of the microbial factor on the formation of the pool of free histamine and other amines in the host organism in relation to the development of allergic responses. In: Medical Microbial Ecology and Functional Nutrition. Vol. 2. The Social and Ecological Consequences of an Imbalance in Animal/Human Microbial Ecology. Moscow: Grant 1998; pp. 227-48.
6. Oleskin AV. Biopolitics. The political potential of the life sciences. Hauppauge (New York): Nova Science Publishers 2012.
7. Oleskin AV. Network structures in biological systems and in human society. Hauppauge (New York): Nova Science Publishers 2014.
8. Oleskin AV, Shenderov BA. Biopolitical approach to rehabilitation: the potential impact of microbial neurochemistry. A review. Regen Med J 2013; 1: 60-7.
9. Roshchina VV. Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells. In: Lyte M, Freestone PP, editors. Microbial endocrinology: interkingdom signaling in infectious disease and health. New York: Springer Science + Business Media 2010; pp. 17-52.
10. Shenderov BA. Innovative products and driver ingredients in the dairy market. Dairy Industry 2013; 6: 62-6.
11. Voropaeva EA. Antibiotic resistance and histamine production by the bacteria isolated from the oro-pharynx ofchildren with bronchial asthma. Antibiotics Chemotherapy 2002; 3: 19-23.
12. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J. Mood and gut feelings. Brain Behav Immun 2010; 24: 9-16. http://dx.doi.org/10.1016/j.bbi.2009.05.058
13. Oleskin AV, Shishov VI, Malikina KD. Symbiotic biofilms and brain neurochemistry. Hauppauge (New York): Nova Science Publishers 2010.
14. Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. Gamma-aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012; 113: 411-7. http://dx.doi.org/10.1111/j.1365-2672.2012.05344.x
15. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behavior. Nature Rev Neurosci 2012; 13(10): 701-12. http://dx.doi.org/10.1038/nrn3346
16. Saulnier DM, Ringel Y, Heyman MB, et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 2013; 4: 17-27. http://dx.doi.org/10.4161/gmic.22973
17. Foster JA. Gut feelings: Bacteria and the brain. Cerebrum [serial on the Internet]. 2013 July 1 [cited 2014 July 30]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788166
18. Shishov VA, Kirovskaya TA, Kudrin VS, Oleskin AV. Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12. Appl Biochem Microbiol 2009; 45(5): 494-7. http://dx.doi.org/10.1134/S0003683809050068
19. Shishov VA. Biogenic amines and their dynamics during the growth of microbial cultures. Cand. Sci. [Biol.] Dissertation. Moscow: Biology Faculty, Moscow State University 2010.
20. Bai AP, Ouyang Q. Probiotics and inflammatory bowel diseases. Postgraduate Med J 2006; 82: 376-82. http://dx.doi.org/10.1136/pgmj.2005.040899
21. Masters RD. Biology and politics: linking nature and nurture. Ann Rev Pol Sci 2001; 4: 345-69. http://dx.doi.org/10.1146/annurev.polisci.4.1.345
22. Blank RH, Hines SM. Biology and political science. London: Routledge 2001.
23. Somit A, Peterson SA. Introduction. In: S. A. Peterson SA, A. Somit A, editors. Research in Biopolitics. Vol.9. Biology and politics. The cutting edge. UK, North America, Japan, etc.: Emerald Group Publ. Ltd. 2011; pp. 3-10.
24. Zhilenkova OG, Shenderov BA, Klodt PM, Kudrin VS, Oleskin AV. Dairy products as potential sources of compounds that modify their consumers' behavior. Dairy Industry 2013; 10: 16-9.
25. Dubynin VA, Kamensky AA, Sapin MP, Sivoglazov VN. Regulatory systems of the human organism. Moscow: Drofa 2003.
26. MedLine Plus. Plasma amino acids. Rockville Pike, Bethesda, MD: U.S. Department of Health and Human Services National Institutes of Health [updated 2014 july 9; cited 2014 July 30]. Available from: http://www.nlm.nih.gov/medlineplus/ency/article/003361.htm
27. Orlov RS, Nozdrachev AD. Normal physiology. Moscow: GEOTAR-Media 2009.
28. Eisenhofer G, Kopin IJ, Goldstein DC. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 2004; 56(3): 331-49. http://dx.doi.org/10.1124/pr.56.3.1
29. Yashin AY, Yashin YI. Measuring options with a TsvetYauza liquid chromtographer equipped with electrochemical detectors. Ros Khim J 2002; 4: 1090-15.
30. Kudrin VS, Klodt PM, Narkevich VB, et al. The behavioral and neurochemical aspects of the antidepressive action of GSB-106, a dipeptide fragment of brain neurotrophic factor BDNF. Exp Clin Pharmacol 2012; 75: 41-5.
31. Khoroshilova IE, Panov PB. Clinical Nutritiology. Moscow: Nauka 2006.
32. Eldrup E. Significance and origin of DOPA, DOPAC and dopamine-sulfate in plasma, tissue and cerebrospinal fluid. Dan Med Bull 2004; 31: 34-62.
33. McPherson RA, Pincus MR, editors. Henry's Clinical Diagnosis and Management by Laboratory Methods. Philadelphia: Elsevier Saunders 2011.
34. Abbott RJ, Pye IF, Nahorski SR. CSF and plasma GABA levels in Parkinson's disease. J Neurol Neurosurg Psychiatry 1982; 45: 253-56. http://dx.doi.org/10.1136/jnnp.45.3.253
35. Potter B, Orfali S. Brain boosters. Foods and drugs that make you smarter. Berkeley (CA): Ronin Publishing 1993.
36. Douglas-Escobar V, Elliott E, Neu J. Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 2013; 167(4): 374-79. http://dx.doi.org/10.1001/jamapediatrics.2013.497
37. Hsiao EY, McDride AW, Hsien S, et al. Microbiota modulates behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155: 1451-63. http://dx.doi.org/10.1016/j.cell.2013.11.024